An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP

Summary

The aim of this study is to evaluate the efficacy of romiplostim administered at every other week in ITP patients who attained stable platelet counts ≥ 50 x 109/L for 4 consecutive weeks after weekly doses of romiplostim.

Timeline

Start

2015-01

Primary completion

2015-12

Completion

2016-01

Drugs

Indications